Olink Proteomics AB is a fast-growing Uppsala-based global company whose world-leading technology and products contribute to the development of precision medicine.
The products are used in medical areas such as cardiovascular disease, cancer, neurological diseases and more.
Based on pioneering research by Professor Ulf Landegren and his group at Uppsala University, Olink Proteomics was founded in 2016. The company has a successful history of developing molecular technology with a broad IP portfolio. Many of these developments have been commercialized through out-licensing to industry-leading partners such as Affymetrix, Life Technologies as well as through the development companies Qlinea and Halo Genomics (now part of Agilent).
STATUS: Exit
